
DarioHealth (DRIO) Stock Forecast & Price Target
DarioHealth (DRIO) Analyst Ratings
Bulls say
DarioHealth is starting to see positive results from their strategy and partnerships, reflected in their consecutive quarters of sequential growth and their strong gross margins. While there may be risks associated with the digital health space and potential challenges in reaching profitability, the company's focus on cost management and access to covered lives puts them in a strong position for potential future success. Additionally, their recent announcement of a new hospital system partner could create a new channel for DRIO and further drive growth.
Bears say
DarioHealth is a DTx company that aims to drive behavior changes and improve health outcomes through its integrated health intelligence platform and proprietary data. While the company has a strong focus on B2C revenue and is seeing some success in the B2B2C market, there are risks of slower revenue growth and potential cash flow issues if cost structure is not rationalized. The company also faces potential challenges of competition and market demand for digital health solutions.
This aggregate rating is based on analysts' research of DarioHealth and is not a guaranteed prediction by Public.com or investment advice.
DarioHealth (DRIO) Analyst Forecast & Price Prediction
Start investing in DarioHealth (DRIO)
Order type
Buy in
Order amount
Est. shares
0 shares